Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:1-2
doi: 10.1161/CIRCULATIONAHA.109.192562
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Related Collections
Right arrowRelated Articles

(Circulation. 2009;120:1-2.)
© 2009 American Heart Association, Inc.


Clinical Summaries

Circulation: Clinical Summaries


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Visually-Guided Balloon Catheter Ablation of Atrial Fibrillation: Experimental Feasibility and First-in-Human Multicenter Clinical Outcome
 
Catheter-based electric isolation of the pulmonary veins can successfully treat patients with paroxysmal atrial fibrillation. Although conceptually straightforward, its clinical application has been hindered by important technical hurdles related to the complexity and patient-to-patient variability of pulmonary venous anatomy, as well as the difficulty in sequentially positioning the ablation catheter in a point-by-point contiguous fashion to isolate the veins. These considerations have led to the development of a balloon ablation catheter equipped with an endoscope that allows direct visualization of the atrial-venous junction and an easily maneuverable optical fiber that projects an arc of ablative laser energy (980 nm) onto the tissue in contact with the balloon face. This novel endoscopic ablation system was used in a series of preclinical porcine experiments and a first-in-human multicenter clinical study. The former demonstrated the feasibility to electrically isolate the pulmonary veins both immediately and persistently. In the clinical phase, a total of 30 patients with paroxysmal atrial fibrillation were treated. In the short term, >90% of the veins were successfully isolated with the balloon system. Long term, the 12-month drug-free freedom from atrial fibrillation after a single procedure was 60%. This study establishes the feasibility for this novel paradigm of catheter ablation of atrial fibrillation. Instead of relying on indirect cues to the location of the ablation catheter in relation to the pulmonary venous anatomy, endoscopic visualization permits the operator to directly visualize the tissue being targeted for ablation, an approach moving ever so closer to approximating the surgical experience. See p . . . [Full Text of this Article]


Related Articles:

Risk Score for Predicting Outcome in Patients With Asymptomatic Aortic Stenosis
Jean-Luc Monin, Patrizio Lancellotti, Mehran Monchi, Pascal Lim, Emmanuel Weiss, Luc Piérard, and Pascal Guéret
Circulation 2009 120: 69-75. [Abstract] [Full Text]

Inhibition of Prolyl Hydroxylase Domain Proteins Promotes Therapeutic Revascularization
Céline Loinard, Amandine Ginouvès, José Vilar, Clément Cochain, Yasmine Zouggari, Alice Recalde, Micheline Duriez, Bernard I. Lévy, Jacques Pouysségur, Edurne Berra, and Jean-Sébastien Silvestre
Circulation 2009 120: 50-59. [Abstract] [Full Text]

Urinary N-Terminal Prohormone Brain Natriuretic Peptide Excretion in Patients With Chronic Heart Failure
Gerard C.M. Linssen, Kevin Damman, Hans L. Hillege, Gerjan Navis, Dirk J. van Veldhuisen, and Adriaan A. Voors
Circulation 2009 120: 35-41. [Abstract] [Full Text]

Opposite Effects of Training in Rats With Stable and Progressive Pulmonary Hypertension
M.L. Handoko, F.S. de Man, C.M. Happé, I. Schalij, R.J.P. Musters, N. Westerhof, P.E. Postmus, W.J. Paulus, W.J. van der Laarse, and A. Vonk-Noordegraaf
Circulation 2009 120: 42-49. [Abstract] [Full Text]

Safety and Efficacy of Recombinant Activated Factor VII: A Randomized Placebo-Controlled Trial in the Setting of Bleeding After Cardiac Surgery
Ravi Gill, Mike Herbertson, Alain Vuylsteke, Peter Skov Olsen, Christian von Heymann, Monty Mythen, Frank Sellke, Frank Booth, and Thomas Andersen Schmidt
Circulation 2009 120: 21-27. [Abstract] [Full Text]

Lipid Treatment Assessment Project 2: A Multinational Survey to Evaluate the Proportion of Patients Achieving Low-Density Lipoprotein Cholesterol Goals
David D. Waters, Carlos Brotons, Cheng-Wen Chiang, Jean Ferrières, JoAnne Foody, J. Wouter Jukema, Raul D. Santos, Juan Verdejo, Michael Messig, Ruth McPherson, Ki-Bae Seung, Lisa Tarasenko for the Lipid Treatment Assessment Project 2 Investigators
Circulation 2009 120: 28-34. [Abstract] [Full Text]

Visually-Guided Balloon Catheter Ablation of Atrial Fibrillation: Experimental Feasibility and First-in-Human Multicenter Clinical Outcome
Vivek Y. Reddy, Petr Neuzil, Sakis Themistoclakis, Stephan B. Danik, Aldo Bonso, Antonio Rossillo, Antonio Raviele, Robert Schweikert, Sabine Ernst, Karl-Heinz Kuck, and Andrea Natale
Circulation 2009 120: 12-20. [Abstract] [Full Text]

Twenty-Five-Year Outcome of Pediatric Coronary Artery Bypass Surgery for Kawasaki Disease
Soichiro Kitamura, Etsuko Tsuda, Junjiro Kobayashi, Hiroyuki Nakajima, Yoshiro Yoshikawa, Toshikatsu Yagihara, and Akiko Kada
Circulation 2009 120: 60-68. [Abstract] [Full Text]